Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


20.05.2019

1 Ann Surg Oncol
2 Anticancer Res
2 Br J Dermatol
1 Cancer Res
1 J Immunother
6 Melanoma Res
2 Nat Med
2 Nat Rev Cancer


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. MIURA JT, Kroon HM, Zager JS
    ASO Author Reflections: International Experience of Isolated Limb Infusion for Melanoma Shows Durable Response.
    Ann Surg Oncol. 2019 May 13. pii: 10.1245/s10434-019-07435.
    PubMed     Text format    


    Anticancer Res

  2. HEINO PJ, Myllari PH, Jahkola TA, Sintonen H, et al
    Long-Term Quality of Life of Melanoma Survivors Is Comparable to that of the General Population.
    Anticancer Res. 2019;39:2633-2640.
    PubMed     Text format     Abstract available

  3. MANTSO T, Vasileiadis S, Lampri E, Botaitis S, et al
    Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma.
    Anticancer Res. 2019;39:2307-2315.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. RUSSELL-JONES R
    A Brighter Future for Melanoma.
    Br J Dermatol. 2019 May 11. doi: 10.1111/bjd.18122.
    PubMed     Text format     Abstract available

  5. KIM TH, Kim HJ, Seo JW, Song KH, et al
    Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities.
    Br J Dermatol. 2019 May 11. doi: 10.1111/bjd.18121.
    PubMed     Text format     Abstract available


    Cancer Res

  6. ANICHINI A
    Progress in Understanding Complexity and Determinants of Immune-Related Prognostic Subsets in Primary Melanoma.
    Cancer Res. 2019;79:2457-2459.
    PubMed     Text format     Abstract available


    J Immunother

  7. LESAGE C, Longvert C, Prey S, Maanaoui S, et al
    Incidence and Clinical Impact of Anti-TNFalpha Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey.
    J Immunother. 2019;42:175-179.
    PubMed     Text format     Abstract available


    Melanoma Res

  8. SCATOZZA F, D'Arcangelo D, Giampietri C, Facchiano F, et al
    Melanogenesis and autophagy in melanoma.
    Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000615.
    PubMed     Text format    

  9. REN Y, Lv Q, Yue W, Liu B, et al
    The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance a
    Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000620.
    PubMed     Text format     Abstract available

  10. MENZIES SW, Liyanarachchi S, Coates E, Smith A, et al
    Estimated risk of progression of lentigo maligna to lentigo maligna melanoma.
    Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000619.
    PubMed     Text format     Abstract available

  11. MARTIN-ALGARRA S, Hinshelwood R, Mesnage S, Cebon J, et al
    Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program.
    Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000608.
    PubMed     Text format     Abstract available

  12. HAGGSTROM L, Duong TA, Thomas B, Brungs D, et al
    Disseminated intravascular coagulation and melanoma: a novel case occurring in metastatic melanoma with BRAF and NRAS mutations and systematic review.
    Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000622.
    PubMed     Text format     Abstract available

  13. NAMIKAWA K, Takahashi A, Mori T, Tsutsumida A, et al
    Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: a single-institution retrospective study.
    Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000617.
    PubMed     Text format     Abstract available


    Nat Med

  14. LONG GV
    Making a difference to many.
    Nat Med. 2019;25:356.
    PubMed     Text format    

  15. TURAJLIC S
    Standing on the shoulders of giants.
    Nat Med. 2019;25:357.
    PubMed     Text format    


    Nat Rev Cancer

  16. DART A
    Immunosuppressive lymphatics.
    Nat Rev Cancer. 2019;19:6-7.
    PubMed     Text format    

  17. HINDSON J
    Targeting endovascular progenitors controls cancer.
    Nat Rev Cancer. 2019;19:128-129.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: